Literature DB >> 12648739

Anxiety and substance use comorbidity among inpatients with schizophrenia.

Renee D Goodwin1, Xavier F Amador, Dolores Malaspina, Scott A Yale, Raymond R Goetz, Jack M Gorman.   

Abstract

OBJECTIVE: To determine the association between lifetime anxiety symptoms and anxiety disorders and substance use disorders among patients with schizophrenia.
METHOD: Participants were 184 inpatients with schizophrenia at the Schizophrenia Research Unit (SRU) at the New York State Psychiatric Institute (NYSPI). Multivariate logistic regression analyses were used to determine the relationship between specific anxiety symptoms and anxiety disorders and substance use disorders among inpatients with schizophrenia.
RESULTS: Anxiety symptoms and anxiety disorders were prevalent among 31.5% of the sample. Panic attacks were associated with a significantly increased odds (OR=7.4 (1.2, 47.1)) of comorbid alcohol or substance use disorders (lifetime). This association was specific to panic attacks and persisted after adjusting for differences in sociodemographic characteristics and comorbid anxiety symptoms and anxiety disorders.
CONCLUSIONS: These findings are consistent with and extend previous data by providing evidence of an association between panic attacks and increased likelihood of substance use disorders among inpatients with schizophrenia. Future studies that determine the nature of this relationship, the sequence of symptom onsets, and examine whether treatment of anxiety can influence the onset or outcome associated with substance use are needed.

Entities:  

Mesh:

Year:  2003        PMID: 12648739     DOI: 10.1016/s0920-9964(02)00292-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

Review 1.  Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Authors:  Henk Temmingh; Dan J Stein
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

2.  Schizophrenia comorbid with panic disorder: evidence for distinct cognitive profiles.

Authors:  Erica Kirsten Rapp; Mandi Lynn White-Ajmani; Daniel Antonius; Raymond Richard Goetz; Jill Martine Harkavy-Friedman; Adam Jonathan Savitz; Dolores Malaspina; Jeffrey Paul Kahn
Journal:  Psychiatry Res       Date:  2012-03-13       Impact factor: 3.222

Review 3.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

Review 4.  Anxiety as a core aspect of schizophrenia.

Authors:  Stefano Pallanti; Andrea Cantisani; Giacomo Grassi
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

Review 5.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

6.  Frequent Comorbidity and Predictors of Social Anxiety in Persons With Schizophrenia: A Retrospective Cohort Study.

Authors:  Alyson Gorun; Kristina Cieslak; Jill Harkavy-Friedman; Andrew Deptula; Deborah Goetz; Raymond Goetz; Dolores Malaspina
Journal:  Prim Care Companion CNS Disord       Date:  2015-09-03

7.  Virtual environments using video capture for social phobia with psychosis.

Authors:  Lina Gega; Richard White; Timothy Clarke; Ruth Turner; David Fowler
Journal:  Cyberpsychol Behav Soc Netw       Date:  2013-05-09

8.  Protocol for a systematic review and meta-analysis of cognitive-behavioural therapy for social anxiety disorder in psychosis.

Authors:  Maria Michail; Max Birchwood; Lynda Tait
Journal:  Syst Rev       Date:  2014-06-11

Review 9.  Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models.

Authors:  Paula Moran; Jennifer Stokes; Julia Marr; Gavin Bock; Lieve Desbonnet; John Waddington; Colm O'Tuathaigh
Journal:  Neural Plast       Date:  2016-09-20       Impact factor: 3.599

Review 10.  Anxiety disorders and schizophrenia.

Authors:  Jacqueline E Muller; Liezl Koen; Seedat Soraya; Robin A Emsley; Daniel J Stein
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.